Aurora Cannabis Profit Margin

The latest profit margin for ACB is -37.92% as of June 2026. That compares with -6.81% in the prior-year period — down 457.2% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Aurora Cannabis's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACB's profit margin moved from -6.81% to -37.92% — a 457.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aurora Cannabis's valuation or profitability profile.

Against Healthcare companies, ACB currently prints -37.92% for profit margin, while the sector average sits near 13.89%. That is roughly 372.9% below the sector mean. Large gaps often invite a closer look at Aurora Cannabis's growth, margins, and balance sheet.

Profit Margin shows how effectively Aurora Cannabis converts resources into returns. At -37.92%, ACB may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6.81% in the prior-year period — down 457.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ACB's profit margin (-37.92%), review year-over-year change from -6.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.